Anterix (ATEX) Asset Writedowns and Impairment (2018 - 2022)

Anterix (ATEX) has reported Asset Writedowns and Impairment for 5 consecutive years, with $127000.0 the latest figure, recorded in Q1 2022.

• For the quarter ending Q1 2022, Asset Writedowns and Impairment rose 182.22% year-over-year to $127000.0; the trailing twelve-month figure through Dec 2021 stood at -$82000.0 (down 254.72% YoY), and the FY2021 full-year result was $85000.0, up 84.78% from the prior year.
• Asset Writedowns and Impairment climbed to $127000.0 in Q1 2022 per ATEX's latest filing, from -$254000.0 in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $534000.0 in Q2 2018 and bottomed at -$254000.0 in Q4 2021.
• Historically, Asset Writedowns and Impairment has averaged $70307.7 across 5 years, with a median of $33000.0 in 2019.
• The widest YoY moves for Asset Writedowns and Impairment: up 246.15% in 2021, down 2409.09% in 2021.
• Over 5 years, Asset Writedowns and Impairment stood at $200000.0 in 2018, then tumbled by 83.5% to $33000.0 in 2019, then plunged by 66.67% to $11000.0 in 2020, then sank by 2409.09% to -$254000.0 in 2021, then surged by 150.0% to $127000.0 in 2022.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $127000.0, -$254000.0, and $112000.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.